BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 36190982)

  • 1. Type 1 and Type 2 Epstein-Barr viruses induce proliferation, and inhibit differentiation, in infected telomerase-immortalized normal oral keratinocytes.
    Singh DR; Nelson SE; Pawelski AS; Cantres-Velez JA; Kansra AS; Pauly NP; Bristol JA; Hayes M; Ohashi M; Casco A; Lee D; Fogarty SA; Lambert PF; Johannsen EC; Kenney SC
    PLoS Pathog; 2022 Oct; 18(10):e1010868. PubMed ID: 36190982
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Epstein-Barr Virus Infection Promotes Epithelial Cell Growth by Attenuating Differentiation-Dependent Exit from the Cell Cycle.
    Eichelberg MR; Welch R; Guidry JT; Ali A; Ohashi M; Makielski KR; McChesney K; Van Sciver N; Lambert PF; Keleș S; Kenney SC; Scott RS; Johannsen E
    mBio; 2019 Aug; 10(4):. PubMed ID: 31431547
    [TBL] [Abstract][Full Text] [Related]  

  • 3. B cells infected with Type 2 Epstein-Barr virus (EBV) have increased NFATc1/NFATc2 activity and enhanced lytic gene expression in comparison to Type 1 EBV infection.
    Romero-Masters JC; Huebner SM; Ohashi M; Bristol JA; Benner BE; Barlow EA; Turk GL; Nelson SE; Baiu DC; Van Sciver N; Ranheim EA; Gumperz J; Sherer NM; Farrell PJ; Johannsen EC; Kenney SC
    PLoS Pathog; 2020 Feb; 16(2):e1008365. PubMed ID: 32059024
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Epstein-Barr virus LMP1 protein promotes proliferation and inhibits differentiation of epithelial cells via activation of YAP and TAZ.
    Singh DR; Nelson SE; Pawelski AS; Kansra AS; Fogarty SA; Bristol JA; Ohashi M; Johannsen EC; Kenney SC
    Proc Natl Acad Sci U S A; 2023 May; 120(20):e2219755120. PubMed ID: 37155846
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ΔNp63α promotes Epstein-Barr virus latency in undifferentiated epithelial cells.
    Van Sciver N; Ohashi M; Nawandar DM; Pauly NP; Lee D; Makielski KR; Bristol JA; Tsao SW; Lambert PF; Johannsen EC; Kenney SC
    PLoS Pathog; 2021 Nov; 17(11):e1010045. PubMed ID: 34748616
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Insufficient PINX1 expression stimulates telomerase activation by direct inhibition of EBV LMP1-NF-κB axis during nasopharyngeal carcinoma development.
    Liu Y; Gong P; Zhou N; Zhang J; He C; Wang S; Peng H
    Biochem Biophys Res Commun; 2019 Jun; 514(1):127-133. PubMed ID: 31027734
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Differentiation-Dependent LMP1 Expression Is Required for Efficient Lytic Epstein-Barr Virus Reactivation in Epithelial Cells.
    Nawandar DM; Ohashi M; Djavadian R; Barlow E; Makielski K; Ali A; Lee D; Lambert PF; Johannsen E; Kenney SC
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179525
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 5-hydroxymethylation of the EBV genome regulates the latent to lytic switch.
    Wille CK; Nawandar DM; Henning AN; Ma S; Oetting KM; Lee D; Lambert P; Johannsen EC; Kenney SC
    Proc Natl Acad Sci U S A; 2015 Dec; 112(52):E7257-65. PubMed ID: 26663912
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Differentiation-Dependent KLF4 Expression Promotes Lytic Epstein-Barr Virus Infection in Epithelial Cells.
    Nawandar DM; Wang A; Makielski K; Lee D; Ma S; Barlow E; Reusch J; Jiang R; Wille CK; Greenspan D; Greenspan JS; Mertz JE; Hutt-Fletcher L; Johannsen EC; Lambert PF; Kenney SC
    PLoS Pathog; 2015 Oct; 11(10):e1005195. PubMed ID: 26431332
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EBV-miR-BART8-3p induces epithelial-mesenchymal transition and promotes metastasis of nasopharyngeal carcinoma cells through activating NF-κB and Erk1/2 pathways.
    Lin C; Zong J; Lin W; Wang M; Xu Y; Zhou R; Lin S; Guo Q; Chen H; Ye Y; Zhang B; Pan J
    J Exp Clin Cancer Res; 2018 Nov; 37(1):283. PubMed ID: 30477559
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Oral Microbiota Alteration and Roles in Epstein-Barr Virus Reactivation in Nasopharyngeal Carcinoma.
    Liao Y; Zhang JB; Lu LX; Jia YJ; Zheng MQ; Debelius JW; He YQ; Wang TM; Deng CM; Tong XT; Xue WQ; Cao LJ; Wu ZY; Yang DW; Zheng XH; Li XZ; Wu YX; Feng L; Ye W; Mu J; Jia WH
    Microbiol Spectr; 2023 Feb; 11(1):e0344822. PubMed ID: 36645283
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Telomerase activity impacts on Epstein-Barr virus infection of AGS cells.
    Rac J; Haas F; Schumacher A; Middeldorp JM; Delecluse HJ; Speck RF; Bernasconi M; Nadal D
    PLoS One; 2015; 10(4):e0123645. PubMed ID: 25856387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. EBV Infection and Glucose Metabolism in Nasopharyngeal Carcinoma.
    Zhang J; Jia L; Tsang CM; Tsao SW
    Adv Exp Med Biol; 2017; 1018():75-90. PubMed ID: 29052133
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Air-Liquid Interface Method To Study Epstein-Barr Virus Pathogenesis in Nasopharyngeal Epithelial Cells.
    Caves EA; Cook SA; Lee N; Stoltz D; Watkins S; Shair KHY
    mSphere; 2018 Jul; 3(4):. PubMed ID: 30021875
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular differentiation regulator BLIMP1 induces Epstein-Barr virus lytic reactivation in epithelial and B cells by activating transcription from both the R and Z promoters.
    Reusch JA; Nawandar DM; Wright KL; Kenney SC; Mertz JE
    J Virol; 2015 Feb; 89(3):1731-43. PubMed ID: 25410866
    [TBL] [Abstract][Full Text] [Related]  

  • 16. NF-κB Signaling Regulates Expression of Epstein-Barr Virus BART MicroRNAs and Long Noncoding RNAs in Nasopharyngeal Carcinoma.
    Verhoeven RJ; Tong S; Zhang G; Zong J; Chen Y; Jin DY; Chen MR; Pan J; Chen H
    J Virol; 2016 Jul; 90(14):6475-88. PubMed ID: 27147748
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epstein-Barr virus infection and nasopharyngeal carcinoma.
    Tsao SW; Tsang CM; Lo KW
    Philos Trans R Soc Lond B Biol Sci; 2017 Oct; 372(1732):. PubMed ID: 28893937
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SPLUNC1 reduces the inflammatory response of nasopharyngeal carcinoma cells infected with the EB virus by inhibiting the TLR9/NF-κB pathway.
    Ou C; Sun Z; Zhang H; Xiong W; Ma J; Zhou M; Lu J; Zeng Z; Bo X; Chen P; Li G; Li X; Li X
    Oncol Rep; 2015 Jun; 33(6):2779-88. PubMed ID: 25891128
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Reduced IRF4 expression promotes lytic phenotype in Type 2 EBV-infected B cells.
    Bristol JA; Brand J; Ohashi M; Eichelberg MR; Casco A; Nelson SE; Hayes M; Romero-Masters JC; Baiu DC; Gumperz JE; Johannsen EC; Dinh HQ; Kenney SC
    PLoS Pathog; 2022 Apr; 18(4):e1010453. PubMed ID: 35472072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of Epstein-Barr Virus Replication in Human Papillomavirus-Immortalized Keratinocytes.
    Guidry JT; Myers JE; Bienkowska-Haba M; Songock WK; Ma X; Shi M; Nathan CO; Bodily JM; Sapp MJ; Scott RS
    J Virol; 2019 Jan; 93(2):. PubMed ID: 30381489
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.